Skip to Content
ChildrenChildren
  • Review
  • Open Access

19 November 2026

13 Pages

Saliva-Based Biomarkers for Non-Invasive Assessment of Pediatric Gastrointestinal Inflammatory Diseases: Current Evidence and Future Perspectives

,
,
and
1
Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy
2
Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy
3
Pediatric Unit, Filippo del Ponte Hospital, 21100 Varese, Italy
4
Department of Paediatric Hepatology Gastroenterology and Transplantation, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy
Children2026, 13(11), 1608;https://doi.org/10.3390/children13111608 
(registering DOI)
This article belongs to the Special Issue Advances in Pediatric Gastroenterology (3rd Edition)

Abstract

Background/Objectives: Endoscopy with biopsy remains central to the diagnosis and assessment of pediatric inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), and celiac disease (CD). However, its invasive nature, procedural burden, cost, and limited suitability for repeated assessment highlight the need for non-invasive biomarkers in children. This review critically evaluates the current evidence for saliva-based biomarkers in these disorders. Methods: A critical narrative literature search was performed in PubMed/MEDLINE and Scopus to identify studies on salivary biomarkers in pediatric IBD, EoE, and CD. Pediatric evidence was prioritized; adult studies were included only when pediatric data were unavailable or limited, and were explicitly distinguished from pediatric findings. Results: Saliva offers major practical advantages in children because collection is painless, inexpensive, repeatable, and feasible without venipuncture or sedation. However, salivary profiles are influenced by oral health, diet, collection procedures, and other pre-analytical factors. In IBD, pediatric evidence remains limited and heterogeneous, with preliminary signals from salivary calprotectin, microbiome, and high-dimensional proteomics. In EoE, salivary microRNAs, volatile organic compounds, and selected microbial taxa show promising but exploratory results, mainly in small cohorts. In CD, salivary anti-tissue transglutaminase IgA has the most interesting pediatric evidence, including data from population-based screening studies. Conclusions: Saliva cannot currently replace established diagnostic tools. The level of evidence varies substantially across diseases: salivary anti-tTG IgA has the most substantial paediatric evidence and may have a complementary role in population-based screening, whereas findings in IBD and EoE remain largely exploratory. Future studies should prioritise methodological standardisation, prospective multicentre validation and direct comparisons with established diagnostic and monitoring standards.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.